Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
other respiratory disease probably the one that you get after investing in VRP for ten years. I will buy in if it gets to £2 as should be completely derisked at that price. Otherwise to much of a gamble and realise the rewards are potentially less but imo the risk will be almost none at £2. Lots of other investments that I have already managed to recoup a lot of loss from years in here. Genuinely hope for many good people here that this works but we have heard the talk always and they have never delivered anything . I will wait until they start to walk the walk but reckon it will be some time yet likely back end of 2021. Keeping an eye on all you guys and wishing you all the very best and keep safe
"Ensifentrine also has potential applications in cystic fibrosis, asthma and other respiratory diseases"...... I wonder what other respiratory diseases they have in mind.
Would be good to see this back up to £1.50 plus..
Think it may be time to come back!!
This presentation imo puts a bit more meat on the bone on the directional thinking of the management. Strategic partnerships to maximise the commercial value. Things are looking good..
Thx - highly professional, positive and who knows - maybe this is our time
August corporate presentation on the website, check it out. Interesting reading, massive potential $$$
Something stirring in the States next week!
Several presentations going ahead an update and up 12pc on the Nasdaq last night!
Maybe just maybe!!
We all know that Ensifentrine is effective against COPD asthma and Cystic Fibrosis.
However the RNS mentions that it is effective against other respiratory diseases!! Do we know which others?
15% Spread . Why ??
I think the MMs are driving this share down so they make their cut on sells and buys which they obviously wouldn't if we all sit on them. Look at this morning there is only a net 40k shares sold representing 13% of the company according to the MMs . Someones having a laugh!!! - at our expense
I have also lost a lot of money on paper, however, having suffered and believed for 11 years, one more is no problem! It’s a shame that I don’t have the conviction to trade albeit VERY predictable. Anyway, interesting times ahead.
Yes indeed. I try to be an investor but ultimately I should have traded it and gambled on the the drop back. Easy with hindsight 20/20.
Good luck all, is going to come good IMHO and from what I know.
Looks like rhodi played a blinder. We will track down I would imagine to low 60s - only hope is that 200 million is a huge fund raise and for that money due diligence would have been done in spades so this will come good if final trial goes well and it should. Although new team have taken a chunk of vrp they do look a strong team who will take us through to a deal so glad they are on-board.
Who knows, lost a lot of money on this damn share!
I do hope so Buddy.
Synairgen and Verona were compared at one time as very similar companies with similar drug products in some sort of race against each other.
This was also backed up in the national press and Investors Chronicle!
We all know that Synairgen has risen by 500 pc recently and apparently there are over 156 drugs worldwide being tested to help alleviate the resultant effects of having COVID-19.
Maybe just maybe Veronas may be one of them and might also be successful treating this along with treating CPOD and CF!
A short trial/feasibilty study on using Ensifentrine on covid 19 survivors with breathing issues would be welcome. I have no medical back ground so maybe ensifentrine would not help. It would be nice to get an out of the blue rns about this, i can but dream...
Presently 10pc up in states!!
From what I understand from an acquaintance, not someone who works for VRP but connected (forgive me for being vague) they are going to need that 200 million for what is already planned and ongoing.
Hold and ride out the bumps is certainly what I am planning to do. As I have said before they haven't got a NASDAQ listing for nothing!
AIMHO and DYOR
I’ve had the same feeling. I also think the announcement will come soon that phase 3 has started which will see the shares lift.
Along with other posts on here I have the feeling there is more news due from the board.
Yes it may drop further over the next few days but something is afoot and it wouldn’t surprise me if it involved treatment of patients who have been left with serious respiratory side effects of COVID-19
Im not too surprised it has dropped a little but from previous experiences wouldnt be surprised if this shot up again in a flash especially as more results come out from the other phase 2 products. I learnt from bitter experience when selling VRP in a panick in case it kept dropping only to see it take off again ,way beyond my selling price. I've decided now just to leave my current shares aloan and just keep adding to them.
It is pleasing to see the the low volume of trading even though the shares have drifted down which I optimistically hoped wouldn't be the case.
In such troubled times taking a long view as apposed to a quick profit or maybe even a long awaited spike to get out was always going to be an attractive option for some. There are no wrongs or rights here, just personal strategy and situation.
Even so, I can't quite believe that there haven't been more buyers especially now given the shares are a bargain given the intrinsic value of the product, the time value created buy the strong fund raising and the incredible hope value of a multi-bagger.
Next week will be interesting.
Good Luck All
AIMHO and DYOR
Atb Rhodi, i understand your decision completely and i wish you well on your future investments.
Kind regards
If the price holds or even increases on the NASDAQ this finishes up in London and maybe by quite a lot!
AIMHO